Physician profile
Charles Snyder
NPI 1811283161
$10,054.22
in general payments reported to CMS, 2019-2025
48 companies · $2,454 in 2025
The $2,454 reported for 2025 was more than what 84% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $777 · 2020: $668 · 2021: $1,132 · 2022: $1,990 · 2023: $1,610 · 2024: $1,423 · 2025: $2,454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,125 · Travel and Lodging: $226 · Education: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,125.42 |
| Travel and Lodging | $226.44 |
| Education | $135.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,473.54 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Abbvie INC. | $1,171.70 | 2019-2025 | Lupron Depot, Botox |
| Pfizer INC. | $818.12 | 2019-2025 | |
| Profound Medical Corp. | $795.74 | 2022-2023 | Tulsa-Pro |
| Boston Scientific Corporation | $754.59 | 2019-2025 | Rezum Generator, Ams 700 Cxr Rte Kit, Spaceoar Vue System - 10ml |
| Procept Biorobotics Corporation | $648.96 | 2025 | |
| Janssen Biotech, INC. | $503.64 | 2019-2025 | Erleada, Akeega |
| Axonics, INC. | $482.26 | 2020-2024 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $354.72 | 2023-2025 | Orgovyx, Gemtesa |
| Bioprotect Medical, INC. | $314.36 | 2025 | Bioprotect Balloon Implant System |
| Medtronic, INC. | $300.21 | 2022-2025 | Interstim |
| Myriad Genetic Laboratories, INC. | $258.80 | 2020-2024 | Prolaris |
| Teleflex LLC | $243.68 | 2021-2025 | Barrigel, Urolift |
| Verity Pharmaceuticals INC. | $231.03 | 2021-2025 | Trelstar |
| Merck Sharp & Dohme LLC | $166.25 | 2021-2025 | Keytruda, Keytruda Qlex |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $138.88 | 2021-2022 | |
| Accord Healthcare, INC. | $128.12 | 2023-2025 | |
| Blue Earth Diagnostics | $124.94 | 2019-2024 | |
| Antares Pharma, INC. | $117.83 | 2019-2024 | Xyosted |
| Endo Pharmaceuticals INC. | $115.96 | 2020-2022 | |
| Agiliti Surgical, INC. | $89.64 | 2023 | Sonablate |
| Tolmar Pharmaceuticals, INC. | $65.85 | 2019-2022 | |
| Urogen Pharma, INC. | $65.38 | 2022-2025 | Jelmyto |
| Dendreon Pharmaceuticals LLC | $54.39 | 2019-2022 | |
| Intuitive Surgical, INC. | $51.35 | 2023 | Da Vinci Surgical System |
| Sun Pharmaceutical Industries INC. | $46.93 | 2022-2024 | |
| Allergan, INC. | $46.03 | 2020-2021 | |
| Ferring Pharmaceuticals INC. | $44.52 | 2024-2025 | Adstiladrin |
| Endo USA, INC. | $41.41 | 2025 | Xiaflex |
| Ambu INC. | $38.24 | 2020-2023 | |
| Astrazeneca Pharmaceuticals Lp | $35.06 | 2025 | Imfinzi |
| Neotract INC. | $32.90 | 2020 | |
| Janssen Scientific Affairs, LLC | $30.12 | 2019 | |
| Innovation Technologies INC | $24.09 | 2025 | Irrisept |
| Laborie Medical Technologies Corp. | $20.74 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Millicent US INC | $19.79 | 2023 | Intrarosa, Femring |
| Halozyme INC | $19.59 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.55 | 2023 | |
| Trevena, INC. | $19.04 | 2021 | |
| Urovant Sciences INC | $18.75 | 2022 | |
| Hollister Incorporated | $18.65 | 2021 | |
| Covidien Lp | $18.35 | 2019 | |
| Tolmar, INC. | $17.67 | 2023 | |
| Novo Nordisk INC | $15.27 | 2024 | Rivfloza |
| Azurity Pharmaceuticals, INC. | $15.01 | 2025 | Azmiro |
| Coloplast Corp | $14.71 | 2022 | |
| Olympus America INC. | $14.38 | 2025 | Itind System |
| Mission Pharmacal Company | $13.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Snyder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.